ipscell.com
New #CRISPR updates: Editas to go public, patent issues, dragons & more - The Niche
A lot has been going on in the CRISPR world. Here are some key CRISPR updates. Editas has filed the paperwork on the road to going public as a company. Such an IPO, should it come to fruition, could raise billions of dollars. Will the other CRISPR companies like Caribou and CRISPR Therapeutics follow suit? Simplistically, … New #CRISPR updates: Editas to go public, patent issues, dragons & more Read More »
Professor Paul Knoepfler, Ph.D.